Published in J Inherit Metab Dis on August 01, 1999
Pregnancy issues in inherited metabolic disorders. J Inherit Metab Dis (2006) 1.01
Inhibition of influenza virus ribonucleic acid polymerase by ribavirin triphosphate. Antimicrob Agents Chemother (1977) 2.71
Random albumin/creatinine ratio for quantification of proteinuria in manifest pre-eclampsia. BJOG (2006) 2.13
Trisodium phosphonoformate, a new antiviral compound. Science (1978) 2.13
Congenital hypothyroidism in Sweden. Incidence and age at diagnosis. Acta Paediatr Scand (1978) 1.94
Hypocalcemia and parathyroid hormone secretion in critically ill patients. Crit Care Med (2000) 1.73
Mode of action, toxicity, pharmacokinetics, and efficacy of some new antiherpesvirus guanosine analogs related to buciclovir. Antimicrob Agents Chemother (1986) 1.71
Enzymatic synthesis of deoxyribonucleotides. X. Reduction of purine ribonucleotides; allosteric behavior and substrate specificity of the enzyme system from Escherichia coli B. J Biol Chem (1966) 1.64
Significance of ribonucleotide reduction in the biosynthesis of deoxyribonucleotides in Escherichia coli. Eur J Biochem (1967) 1.63
Genotyping is a valuable diagnostic complement to neonatal screening for congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency. J Clin Endocrinol Metab (1999) 1.56
Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci U S A (1974) 1.51
Arthritis in DBA/1 mice induced with passively transferred type II collagen immune serum. Immunohistopathology and serum levels of anti-type II collagen auto-antibodies. Scand J Immunol (1990) 1.51
The odontogenic keratocyst: a benign cystic tumor? J Oral Maxillofac Surg (1984) 1.51
Primary Sjögren's syndrome in patients with multiple sclerosis. Neurology (1992) 1.49
Active smoking and a history of smoking are associated with enhanced prostaglandin F(2alpha), interleukin-6 and F2-isoprostane formation in elderly men. Atherosclerosis (2005) 1.49
Identification of the stable free radical tyrosine residue in ribonucleotide reductase. EMBO J (1986) 1.47
Automated pre-ejection period variation indexed to tidal volume predicts fluid responsiveness after cardiac surgery. Acta Anaesthesiol Scand (2009) 1.46
The European Union Directive on Clinical Research: present status of implementation in EU member states' legislations with regard to the incompetent patient. Intensive Care Med (2005) 1.42
Uncompensated blood loss is not tolerated during acute normovolemic hemodilution in anesthetized pigs. Anesth Analg (1998) 1.42
Isolation and characterization of calf liver thioredoxin. J Biol Chem (1974) 1.39
Altered brain white matter integrity in healthy carriers of the APOE epsilon4 allele: a risk for AD? Neurology (2006) 1.38
Gastrointestinal transit of amoxicillin modified-release tablets and a placebo tablet including pharmacokinetic assessments of amoxicillin. Scand J Gastroenterol (1996) 1.38
Regional variations of iodine nutrition and thyroid function during the neonatal period in Europe. Biol Neonate (1986) 1.37
Evidence for two different classes of redox-active cysteines in ribonucleotide reductase of Escherichia coli. J Biol Chem (1989) 1.36
Missense mutations in the human glutathione synthetase gene result in severe metabolic acidosis, 5-oxoprolinuria, hemolytic anemia and neurological dysfunction. Hum Mol Genet (1997) 1.36
Antiherpetic activity and mechanism of action of 9-(4-hydroxybutyl)guanine. Antiviral Res (1983) 1.35
Pyrophosphate analogues as inhibitors of herpes simplex virus type 1 DNA polymerase. Biochim Biophys Acta (1980) 1.34
Inhibition of gamma-glutamylcysteine synthetase by cystamine: an approach to a therapy of 5-oxoprolinuria (pyroglutamic aciduria). Biochem Biophys Res Commun (1977) 1.34
Antibody dependent cytolytic effector lymphocytes (K cells) in human blood. J Reticuloendothel Soc (1975) 1.33
The timing of glucocorticoid administration in rheumatoid arthritis. Ann Rheum Dis (1997) 1.33
Enzymatic synthesis of deoxyribonucleotides. IX. Allosteric effects in the reduction of pyrimidine ribonucleotides by the ribonucleoside diphosphate reductase system of Escherichia coli. J Biol Chem (1966) 1.27
Nucleic acid hybridization, a method to determine effects of antiviral compounds on herpes simplex virus type 1 DNA synthesis. Antiviral Res (1984) 1.25
Altered deactivation in individuals with genetic risk for Alzheimer's disease. Neuropsychologia (2008) 1.25
Inhibiting effect of (RS)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine on varicella-zoster virus replication in cell culture. Antimicrob Agents Chemother (1987) 1.25
Analysis of oligonucleotide probe affinities using surface plasmon resonance: a means for mutational scanning. Anal Biochem (1997) 1.24
Glycerol production in subcutaneous adipose tissue in lean and obese humans. J Clin Invest (1992) 1.24
Incidence of congenital hypothyroidism: retrospective study of neonatal laboratory screening versus clinical symptoms as indicators leading to diagnosis. Br Med J (Clin Res Ed) (1984) 1.23
Evaluation of Gentian cystatin C reagent on Abbott Ci8200 and calculation of glomerular filtration rate expressed in mL/min/1.73 m(2) from the cystatin C values in mg/L. Scand J Clin Lab Invest (2007) 1.21
Critical determinants of antiherpes efficacy of buciclovir and related acyclic guanosine analogs. Antiviral Res (1987) 1.21
T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. J Immunol (1989) 1.21
Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli. Chembiochem (2001) 1.20
Study of Fab and F(ab') 2 from rabbit IgG for capacity to induce lymphocyte-mediated target cell destruction in vitro. Int Arch Allergy Appl Immunol (1972) 1.20
Metabolism and mode of action of (R)-9-(3,4-dihydroxybutyl)guanine in herpes simplex virus-infected vero cells. J Biol Chem (1986) 1.20
Pyroglutamic aciduria (5-oxoprolinuria), an inborn error in glutathione metabolism. Pediatr Res (1974) 1.19
Routine oxytocin in the third stage of labour: a placebo controlled randomised trial. Br J Obstet Gynaecol (1997) 1.19
9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplication. Antimicrob Agents Chemother (1983) 1.18
Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome? Ann Rheum Dis (2000) 1.16
Detection of antigen-antibody interactions by surface plasmon resonance. Application to epitope mapping. J Mol Recognit (1991) 1.16
Mental development in congenital hypothyroidism after neonatal screening. Arch Dis Child (1987) 1.15
Immunohistochemical localisation of tissue plasminogen activator and urokinase in the vessel wall. J Clin Pathol (1985) 1.13
Corticosteroid treatment of experimental arthritis retards cartilage destruction as determined by histology and serum COMP. Rheumatology (Oxford) (2004) 1.13
Cytotoxicity of human lymphocytes induced by rabbit antibodies to chicken erythrocytes. Inhibition by normal IgG and by human myeloma proteins of different IgG subclasses. Immunology (1973) 1.11
Genetic regulation of human anti-malarial antibodies in twins. Proc Natl Acad Sci U S A (1992) 1.11
Reversible inhibition of cellular metabolism by ribavirin. Antimicrob Agents Chemother (1978) 1.11
Ribonucleotide reductase rom regenerating rat liver. Eur J Biochem (1969) 1.10
Kinetic analysis in cell culture of the reversal of antiherpes activity of nucleoside analogs by thymidine. Antimicrob Agents Chemother (1983) 1.09
Sequential studies of serum blocking activity in rats bearing chemically induced primary bowel tumors. J Natl Cancer Inst (1975) 1.08
In vitro and in vivo erosion of two different hydrophilic gel matrix tablets. Eur J Pharm Biopharm (1998) 1.07
Metabolic effects of starvation in the eel, Anguilla anguilla L. Comp Biochem Physiol A Comp Physiol (1973) 1.07
Long-term clinical outcome in patients with glutathione synthetase deficiency. J Pediatr (2001) 1.07
Chicken antibodies: a clinical chemistry perspective. Ups J Med Sci (1999) 1.06
Antigenic sites in carcinoembryonic antigen. Cancer Res (1989) 1.06
Dynamics of carbon dioxide elimination following ventilator resetting. Chest (1995) 1.06
Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections. Immunol Res (2000) 1.06
A novel assay for influenza virus quantification using surface plasmon resonance. Vaccine (2009) 1.06
Characterization of the humoral immune response in Plasmodium falciparum malaria. III. Factors influencing the coexpression of antibody isotypes (IgM and IgG-1 to 4). Clin Exp Immunol (1986) 1.05
Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus. Eur J Clin Invest (1998) 1.05
Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study. Dement Geriatr Cogn Disord (2010) 1.04
Pyroglutamic aciduria. Studies in an infant with chronic metabolic acidosis. Acta Paediatr Scand (1974) 1.04
Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine. Antimicrob Agents Chemother (1985) 1.04
Phosphorylation of four acyclic guanosine analogs by herpes simplex virus type 2 thymidine kinase. Antimicrob Agents Chemother (1984) 1.03
Deoxyribonucleotide pools during liver regeneration. Eur J Biochem (1973) 1.03
The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction (2006) 1.03
Antiherpes activity of [E]-5-(1-propenyl)-2'-deoxyuridine and 5-(1-propenyl)-1-beta-D-arabinofuranosyluracil. Antiviral Res (1981) 1.02
Ameloblastoma of the jaws. An analysis of a consecutive series of all cases reported to the Swedish Cancer Registry during 1958--1971. Acta Pathol Microbiol Scand A (1978) 1.02
Intraosseous angiolipoma of the mandible. Oral Surg Oral Med Oral Pathol (1980) 1.01
Influence of optical probing with YOYO on the electrophoretic behavior of the DNA molecule. Electrophoresis (1996) 1.01
Neonatal screening for congenital adrenal hyperplasia: 17-hydroxyprogesterone levels and CYP21 genotypes in preterm infants. Pediatrics (2001) 1.01
Immunization of mice and rabbits by intrasplenic deposition of nanogram quantities of protein attached to Sepharose beads or nitrocellulose paper strips. J Immunol Methods (1987) 1.00
Growth failure, encephalopathy, and endocrine dysfunctions in two siblings, one with 5-oxoprolinase deficiency. Eur J Pediatr (1997) 0.99
Serum cystatin C and the risk of Alzheimer disease in elderly men. Neurology (2008) 0.99
Administration of interferon to an infant with congenital rubella syndrome involving persistent viremia and cutaneous vasculitis. Acta Paediatr Scand (1976) 0.99
Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome. J Autoimmun (1989) 0.99
Lactate release from the subcutaneous tissue in lean and obese men. J Clin Invest (1994) 0.98
Relationship between urinary albumin and albumin/creatinine ratio during normal pregnancy and pre-eclampsia. Scand J Clin Lab Invest (2004) 0.98
T-cell receptor V beta haplotype and complement component C5 play no significant role for the resistance to collagen-induced arthritis in the SWR mouse. Immunology (1991) 0.97
5-Oxoprolinuria: a cause of neonatal metabolic acidosis. Acta Paediatr (2001) 0.97
Failure to detect MHC class II associations of the human immune response induced by repeated malaria infections to the Plasmodium falciparum antigen Pf155/RESA. Int Immunol (1991) 0.97
P53 auto-antibodies in non-small cell lung cancer patients can predict increased life expectancy after radiotherapy. Anticancer Res (1998) 0.97
Psychological reactions in 102 families with a newborn who has a falsely positive screening test for congenital hypothyroidism. Acta Paediatr Scand Suppl (1983) 0.97
The effect of hyaluronan on bone and soft tissue and immune response in wound healing. J Periodontol (2001) 0.97
Declining levels of HIV P24 antigen in serum during treatment with foscarnet. Lancet (1988) 0.97
Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain. Brain Res (1998) 0.96
Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res (1999) 0.96
Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden. Pediatrics (1998) 0.96
Serum concentrations of cartilage oligomeric matrix protein, fibrinogen and hyaluronan distinguish inflammation and cartilage destruction in experimental arthritis in rats. Rheumatology (Oxford) (2002) 0.95
Patients with genetic defects in the gamma-glutamyl cycle. Chem Biol Interact (1998) 0.95
Hypophosphatasia affecting the permanent dentition. J Oral Pathol Med (1996) 0.95
Induction and repair of single-strand DNA breaks after X-irradiation of human fibroblasts deficient in glutathione. Int J Radiat Biol Relat Stud Phys Chem Med (1981) 0.95
Allergic dermatitis (sweet itch) of Icelandic horses in Sweden: an epidemiological study. Equine Vet J (1987) 0.95
Functional residual capacity and ventilation homogeneity in mechanically ventilated small neonates. J Appl Physiol (1985) (1992) 0.95